Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

First patient dosed in Phase IIb imaging for Brain Mets

by admin April 28, 2025
April 28, 2025
First patient dosed in Phase IIb imaging for Brain Mets

Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets

Download the PDF here.

This post appeared first on investingnews.com

previous post
Binding Commitments Received for A$1.0 Million under Convertible Note Placement
next post
RHI: Acqn of royalty over Sandstone Gold Project tenements

Related Posts

Antilles Gold to Raise $1.0M for Working Capital

February 18, 2025

Standard Uranium Closes Final Tranche of Private Placement

October 29, 2025

Opawica Explorations Inc. Drills 28m of Mineralization with...

April 25, 2025

Silver47 Closes First Tranche of Non-brokered Private Placement

March 6, 2025

OTCQB Venture Virtual Investor Conference Agenda Announced for...

August 5, 2025

Walker Lane Resources Ltd. Announces Closing of Private...

July 24, 2025

Crypto Market Recap: Utah Forwards Blockchain Bill, ByBit...

March 11, 2025

Oil and Gas Price Update: Q1 2025 in...

April 24, 2025

Collaboration with DuPont Water Solutions to Test Lithium...

April 17, 2025

Gold vs. Platinum: Which is the True Metal...

February 14, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved